News

Horizon Europe Strategic Plan 2025-2027 adopted

Published on | 1 year ago

Programmes Horizon Europe

On 20 March, the Commission adopted the 2nd Strategic Plan for Horizon Europe. It sets out three key strategic orientations for the EU's research & innovation funding for the three last years of the programme (2025-2027):

  • Green transition
  • Digital transition
  • More resilient, competitive, inclusive and democratic Europe

These key strategic orientations are the guiding principles for Horizon Europe and will be implemented through the work programmes. In the next months, the main Horizon Europe Work Programme 2025 will be developed following these orientations.

The newly adopted plan has the following overarching principles: open strategic autonomy and securing Europe's leading role in developing and deploying critical technologies.

In addition, the strategic plan: 

  • Identifies 9 new European co-funded and co-programmed partnerships, namely: Brain Health, Forests and Forestry for a Sustainable Future, Innovative Materials for EU, Raw Materials for the Green and Digital Transition, Resilient Cultural Heritage, Social Transformations and Resilience, Solar Photovoltaics, Textiles of the Future, and Virtual Worlds; 
  • Provides an overview on the achievement of EU Missions over their first years; 
  • Introduces the New European Bauhaus Facility (NEB). NEB aims to bring a wide range of stakeholders together to reimagine and implement sustainable and inclusive living in Europe and beyond. The NEB Facility will have an R&I component as part of Horizon Europe as well as a roll-out component that will be delivered through synergies with other EU programmes; 
  • Commits to a target of 10% of the Horizon Europe’s total budget 2025-2027 dedicated to biodiversity-related topics
  • Addresses the issue of balance of research and innovation by commiting to provide a balanced support to activities with a range of technology readiness & maturity levels, as well as the issue of integration of social sciences and humanities. 


More information is available on the dedicated Commission website, including a press release, the full text of the Horizon Europe strategic plan 2025-2027 (text) and a summary factsheet.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1607 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.